Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

09 May 2016 : Review article  

Dexamethasone Prevents Postoperative Nausea and Vomiting After Cesarean Section Under Neuraxial Anesthesia: A Systematic Review and Meta-Analysis

An-liang LiADEF, Hong GaoACD, Shao-feng LinB, Yan-qiu LiuE, Yong-qiang YinF

DOI: 10.12659/MSRev.897540

Med Sci Rev 2016; 3:64-72


Background:  We performed a meta-analysis to assess the effect of dexamethasone in reducing the occurrence of postoperative nausea or vomiting (PONV) and pruritus in parturient receiving neuraxial anesthesia with neuraxial opioids among cesarean section. Material abd Methods: We searched PubMed, the Cochrane Central Register of Controlled Trials and EMBASE for all randomized controlled trials to compare dexamethasone with placebo for the prevention of PONV in parturients under a neuraxial anesthetic methods. Data were extracted independently by the authors. The incidence of PONV and pruritus in 24 hours, use of rescue anti-emetics, early pain scores at or around 4 hours and postoperative pain scores at 24 hours were statistics. Using the Review Manager (Review Manager version 5.3 (Cochrane Collaboration, Oxford, UK) complete meta-analysis and calculating the Odds ratio(OR) and 95% confidence interval (CI). Results: Finally, seven randomized controlled trails were included in the study. From these trials, total 484 patients were analyzed with 241 receiving dexamethasone and 243 receiving placebo. At 24 hours after surgery, compared with placebo, dexamethasone reduced the incidence of postoperative nausea (OR [95% CI]=0.42 [0.26, 0.67]), postoperative vomiting (OR [95% CI]=0.38[0.24,0.62]) and the use of rescue antiemetic (OR [95% CI]=0.21 [0.10, 0.44]). Dexamethasone also reduced early pain scores at or around 4 hours (MD [95% CI]=–0.85[–1.59, –0.10]) and 24-hour visual analog pain scores (MD [95% CI]=–0.89(–1.35, –0.43)]. However, dexamethasone cannot reduce the incidence of pruritus (OR [95% CI]=0.86 [0.54, 1.38]). Conclusions: Dexamethasone is an effective antiemetic for parturient receiving neuraxial opioids for cesarean section. However, dexamethasone was not unavailable for against neuraxial opioid-induced pruritus.

Keywords: Anesthesia, Spinal, Cesarean Section, Dexamethasone, Postoperative Nausea and Vomiting

Add Comment 0 Comments


01 May 2023 : Editorial  

Editorial: Twenty Years On from Sequencing the Human Genome, Personalized/Precision Oncology Prepares to Meet the Challenges of Checkpoint Inhibitor Therapy

Dinah V. Parums
Science Editor, Medical Science Monitor, International Scientific Information, Inc., Melville, NY, USA

DOI: 10.12659/MSM.940911

Med Sci Monit 2023; 29:e940911


In Press

31 May 2023 : Review article  

Prevalence, Diagnosis, and Management of Eclampsia and the Need for Improved Maternal Care: A Review

Med Sci Monit In Press; DOI: 10.12659/MSM.939919  

30 May 2023 : Clinical Research  

A Case-Control Study of Cognitive Function in Patients with End-Stage Renal Disease Before and After Hemodi...

Med Sci Monit In Press; DOI: 10.12659/MSM.940409  

30 May 2023 : Review article  

A Review of the Role of the Zebrafish (Danio reiro) in Preclinical and Clinical Models of Biomarker Identif...

Med Sci Monit In Press; DOI: 10.12659/MSM.940550  

30 May 2023 : Database Analysis  

The COVID-19 Crisis and the Incidence of Alcohol-Related Deaths in Poland

Med Sci Monit In Press; DOI: 10.12659/MSM.940904  

Most Viewed Current Articles

13 Nov 2021 : Clinical Research  

Acceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...

DOI :10.12659/MSM.932788

Med Sci Monit 2021; 27:e932788


30 Dec 2021 : Clinical Research  

Retrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis o...

DOI :10.12659/MSM.935379

Med Sci Monit 2021; 27:e935379

08 Mar 2022 : Review article  

A Review of the Potential Roles of Antioxidant and Anti-Inflammatory Pharmacological Approaches for the Man...

DOI :10.12659/MSM.936292

Med Sci Monit 2022; 28:e936292

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750